Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

PHASE4CompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

May 31, 2003

Study Completion Date

April 30, 2007

Conditions
Acute Myeloid Leukemia
Interventions
DRUG

Topotecan

DRUG

Fludarabine

DRUG

Cytarabine

Trial Locations (16)

Unknown

Hospital Juan Canalejo, A Coruña

Hospital Ntra. Sra. de Sonsoles, Ávila

Hospital germans Trias i Pujol, Badalona

Centro Médico Teknon, Barcelona

Hospital Sant Pau, Barcelona

Hospital Vall d'Hebron, Barcelona

Hospital General Yagüe, Burgos

Hospital de Jerez, Cadiz

Complejo hospitalario Xeral-Calde, Lugo

Hospital Clínico Universitario San Carlos, Madrid

Hospital Ramón y Cajal, Madrid

Hospital Virgen de la Victoria, Málaga

Hosptal Joan XXIII, Tarragona

Hospital Verge de la Cinta, Tortosa

Hospital Rio Hortega, Valladolid

Hospital Clinico Lozano Blesa, Zaragoza

All Listed Sponsors
lead

PETHEMA Foundation

OTHER

NCT00488709 - Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia | Biotech Hunter | Biotech Hunter